Cancermedicin på G!

+23% igår fredag Stor potential framöver, tror jag! AVEO rusar! http://finance.yahoo.com/news/AVEO-regains-rights-to-apf-316145121.html?x=0&.v=1 CAMBRIDGE, Mass. (AP) -- AVEO Pharmaceuticals Inc. said Thursday it regained rights to a potential cancer therapy from Merck & Co. The company said it regained rights to AV-299, which is now in midstage development as a potential lung cancer treatment. AVEO received an $8.5 million payment from Merck for initiating that study, which is expected to produce data in late 2011.